Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

[CYP2D61, CYP2D610 Co-Expressed with CYPOR in Bac-to-Bac Expression System and Activity Determination].

[Expression of Human CYP2E1 in Insect Cells Using Bac-to-bac Expression System].

Comparison of Catalytical Activity and Stereoselectivity Between the Recombinant Human Cytochrome P450 2D6.1 and 2D6.10.

Study Heterogenous Expression and Activity Determination of Human Cytochrome P450 2B6

Expression and Characterization of Human Cytochrome P450 1A2

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms in Vitro

Influence Of Various Polymorphic Variants Of Cytochrome P450 Oxidoreductase (Por) On Drug Metabolic Activity Of Cyp3a4 And Cyp2b6

[Distinguishing CYP2D6 Homozygous and Heterozygous Extensive Metabolizers by Dextromethorphan Phenotyping].

Discovery and Enzyme Kinetic Characterization of Novel CYP2D6 Variants

Frequency of CYP2D610 and 14 Alleles and Their Influence on the Metabolic Activity of CYP2D6 in a Healthy Chinese Population

In Vitro Functional Characterization of 37 CYP2C9 Allelic Isoforms Found in Chinese Han Population.

In Vitro Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population.

DETERMINATION OF CYP2D6 ACTIVITY BY CAPILLARY GAS CHROMATOGRAPHY AND ITS APPLICATION IN METABOLIC PHENOTYPING

Expressing in Vitro and Functional Study of Human CYP2D6 Gene

Correlation of Genetic Polymorphism of Cytochrome P4502D6 with Dextromethorphan Oxidative Metabolism in Chinese.

Establishment of the Recombinant Human Cytochrome P450 2C9 Saccharomyces Cerevisiae Expression Systems in Vitro and the Impact of Gene Polymorphism on Drug-Drug Interactions

Co-expression Model and Inhibitor Screening of the Human P450 CYP2C19 with the CYPOR and CYPb5

Catalytic Activities of Human Cytochrome P450 2C91, 2C93 and 2C9*13

Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

Effect of 24 Cytochrome P450 2D6 Variants Found in the Chinese Population on Atomoxetine Metabolism in Vitro

[CYP2D6*1, CYP2D6*10 Co-Expressed with CYPOR in Bac-to-Bac Expression System and Activity Determination].